HARBIN, China--(BUSINESS WIRE)--China Kangtai Cactus Biotech Inc. (OTCBB:CKGT - News), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that it has entered into an equity purchase agreement with Kodiak Capital Group, LLC (hereinafter referred to as Kodiak) to support its expansion and growth strategies.
The company intends to use $1 million in proceeds to help finance marketing projects for its cactus-based cigarettes and soft drinks. The company also plans to acquire additional equipment for its newly purchased cigarette manufacturing plant and its soft drinks operations to enhance current and future production capacity.
China Kangtai CEO Jinjiang Wang said, “This financing supports another major step forward in our expansion strategy. Demand for cactus-based products, particularly cigarettes, is growing rapidly every year. We are confident that the financing can help us greatly enhance our marketing efforts and business growth.”
Robert McCarthy, Managing Director of Kodiak Capital Group said, “We are pleased with the opportunity to invest in the exciting growth of China Kangtai Cactus. China has long history of using herbal-based products as medicine or regular dietary supplements. By leveraging our financial support, we believe that China Kangtai Cactus will further strengthen its enormous growth potential.”
About Kodiak Capital Group, LLC.
Kodiak Capital Group, LLC is engaged in assisting growth companies in all facets of their long term strategy by providing capital and progressive business solutions. Kodiak manages a portfolio of investments in public and private equities. Founded in 2009, Kodiak has transacted in excess of $400 million in financing for companies across a multitude of industries, including biotechnology, business services, consumer products, defense, healthcare, Internet, manufacturing, medical devices, natural resources, oil and gas, renewable energy and wireless communications. Headquartered in New York City; Kodiak has assisted companies throughout North America, China and Australia. More information may be found at http://www.kodiak-capital.com.
About China Kangtai Cactus Biotech, Inc.
China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai’s high-quality “green” products are sold throughout China via a distribution network that covers 12 of China’s 23 provinces and two of China’s four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.
China Kangtai’s online investor kit, including an investment profile, press releases, current price quotes, stock charts and more is available at http://www.hawkassociates.com/profile/ckgt.cfm. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
